The largest database of trusted experimental protocols

Massarray iplex gold platform

Manufactured by Labcorp
Sourced in United States

The MassARRAY iPLEX Gold platform is a high-throughput, mass spectrometry-based genotyping system. It is designed for the analysis of genetic variations, including single nucleotide polymorphisms (SNPs) and small insertions/deletions.

Automatically generated - may contain errors

7 protocols using massarray iplex gold platform

1

Vitamin D Pathway Genetic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The previous study reported the criteria for candidate genes and SNPs related to the synthesis, transport, and catabolism of vitamin D [18 (link)]. We first selected NADSYN1/DHCR7 (rs1790349 and rs12785878), GC (rs222040, rs1155563, rs16846876, rs2298849, rs7041, and rs4588), CYP24A1 (rs2209314), CYP2R1 (rs10741657), and VDR (rs2228570, rs7975232, and rs757343) as candidate SNPs. Based on the Hardy–Weinberg equilibrium (r2 > 0.8) and the genotype success rate (>95%), five transport SNPs (GC-rs1155563, GC-rs16846876, GC-rs2298849, GC-rs7041, and GC-rs4588), and one catabolism SNP (CYP24A1-rs2209314) were selected. SNP genotyping was performed using the Sequenom MassARRAY iPLEX Gold platform (Sequenom, San Diego, CA, USA).
+ Open protocol
+ Expand
2

Genetic Predictors of Vitamin D Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single nucleotide polymorphisms (SNPs) involved in vitamin D synthesis and metabolism pathways were selected according to previous studies reported among pregnant or non‐pregnant population. Besides, these SNPs locate in the functional domain of genes and play a vital role in vitamin metabolism included in the database of NCBI VDR (rs10735810, rs3847987, rs1544410, rs7968585, rs2408876, rs10783219); GC (rs7041, rs4588, rs2282679, rs1155563, rs12512631, rs222020, rs16847015, rs17467825, rs2070741, rs2298849, rs16846876, rs842999, rs222035, rs3755967, rs11939173, rs2298850, rs12512631); CYP2R1 (rs2060793, rs10741657, rs1993116, rs7116978, rs12794714, rs1562902, rs10766197, rs10500804, rs10766197, rs10877012, rs11023374); CYP24A1 (rs6013897, rs927650, rs2248137, rs6068816, rs73913757, rs2209314, rs2762939, rs17470271); CYP27B1 (rs4646536, rs703842, rs10877012, rs118204009); CYP3A43 (rs680055, rs2242480); NADSYN1/DHCR7 (rs3829251, rs1790349, rs12785878, rs7944926, rs12800438, rs3794060, rs4945008, rs4944957); and RXRA (rs9409929, rs11185644) were selected as candidate SNPs. DNA was extracted from the peripheral blood leukocytes using a Rapid DNA Extraction and Detection Kit (Tiangen) according to the manufacturer's protocol, and SNP genotyping was conducted and analyzed by using the MassARRAY iPLEX Gold platform (Sequenom).
+ Open protocol
+ Expand
3

Vitamin D Genetics and Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to previous studies, relative SNPs have been selected in genes involved in vitamin D synthesis and metabolic pathways. In addition, these SNPs are located in the functional domain and play a vital role in vitamin metabolism from the NCBI database. The following were selected as candidate SNPs: VDR (rs10735810, rs3847987, rs1544410, rs7968585, rs2408876, rs10783219); GC (rs7041, rs4588, rs2282679, rs1155563, rs12512631, rs222020, rs16847015, rs17467825, rs2070741, rs2298849, rs16846876, rs842999, rs222035, rs3755967, rs11939173, rs2298850, rs12512631); CYP2R1 (rs2060793, rs10741657, rs1993116, rs7116978, rs12794714, rs1562902, rs10766197, rs10500804, rs10766197, rs10877012, rs11023374); CYP24A1 (rs6013897, rs927650, rs2248137, rs6068816, rs73913757, rs2209314, rs2762939, rs17470271); CYP27B1 (rs4646536, rs703842, rs10877012, rs118204009); CYP3A43 (rs680055, rs2242480); NADSYN1/DHCR7 (rs3829251, rs1790349, rs12785878, rs7944926, rs12800438, rs3794060, rs4945008, rs4944957); RXRA (rs9409929, rs11185644). A Rapid DNA Extraction and Detection Kit (Tiangen) was used to extract DNA from peripheral blood leukocytes according to the manufacturer's protocol, and SNP genotyping was conducted and analyzed using the MassARRAY iPLEX Gold platform (Sequenom).
+ Open protocol
+ Expand
4

Genotyping Protocol for Genetic Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each participant, 5 ml peripheral venous blood was collected after signing informed consent and before drug used. Genomic DNA was extracted using the phenol-chloroform method within 1–2 weeks and saved in −20°C refrigerator. SNP genotyping was performed with the Sequenom MassARRAY iPLEX Gold platform (Sequenom, San Diego, CA, United States) (Ikeda et al., 2008 (link)). Primers were designed using the MassARRAY Assay Design 3.1 software. Two amplification primer systems were built with the balance of capturing as many SNP loci as possible while limiting costs. Genomic fragments containing SNPs were amplified by polymerase chain reaction (PCR) in a total reaction volume of 5 μl, which included 20–50 ng of genomic DNA, in two 384-well plates using the ABI GeneAmp® 9700 384 Dual. Purified and specific genotyping primers were used to amplify target sites. Genotypes were automatically called by MassARRAY Typer 4.0 and verified manually. To ensure the accuracy of genotyping, 32 samples were duplicated for quality control, and no genotyping errors were found. Additionally, each 384-well plate had four blank controls. Any individual whose missing genotypes were greater than 50% was excluded from further statistical analysis.
+ Open protocol
+ Expand
5

Genome-wide Genotyping and Validation of Central China Cohort

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genotyping in the discovery stage for the central China cohort was conducted by Illumina 610-Quad Human Beadchip array (Illumina, Inc., San Diego, CA, USA). The genomic DNA was isolated from peripheral blood mononuclear cells (PBMCs) with standard procedures using Flexi Gene DNA kits (QIAGEN GmbH, Hilden, Germany) and was diluted to working concentrations of 50 ng/μl for genome-wide genotyping and 15–20 ng/μl for the validation study. The SNPs in the X chromosome for the validation stage were genotyped using the Sequenom MassArray iPlex Gold platform (Sequenom, Inc., San Diego, CA, USA).
+ Open protocol
+ Expand
6

DNA Extraction and SNP Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was either isolated on the BioRobot Universal with the QIAamp DNA Blood BioRobot MDx Kit (Qiagen, Hilden, Germany) and eluted in Qiagen buffer AE (10 mM Tris-Cl 0.5 mM EDTA; pH 9.0), or with the Gentra Autopure LS machine using the Puregene Genomic DNA purification Kit (Gentra Systems, Minneapolis, MN 55441 USA), or manually using the MasterPure TM DNA Purification Kit for Blood Version II (Epicentre® Biotechnologies, Madison, WI, USA). SNPs were genotyped with the iPLEX Gold massarray platform (Sequenom) at the Centre for Integrative Genetics, Norwegian University of Life Sciences, Ås, Norway.
+ Open protocol
+ Expand
7

Mitochondrial Haplogroup Genotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
We selected 15 mtSNPs that capture common European mitochondrial haplogroup variation based on previous publications (Raby et al., 2007 (link); Mitchell et al., 2014 (link)). mtSNPs were genotyped on the Sequenom iPLEX Gold MassArray platform (Sequenom, Inc., San Diego, CA) in the University of Minnesota Genomics Core. PCR and extension primers were designed using the MassARRAY Assay Design 3.0 software, and amplification and single base extension reactions were performed according to instructions (Tang et al., 1999 (link), 2004 (link)). Extension product sizes were determined using Sequenom’s Compact MALDI-TOF mass spectrometer. The resulting mass-spectra were converted to genotype data using SpectroTYPER-RT software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!